Administration on Disabilities, President's Committee for People With Intellectual Disabilities, 19188 [2016-07654]
Download as PDF
19188
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Administration on Disabilities,
President’s Committee for People With
Intellectual Disabilities
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The President’s Committee
for People with Intellectual Disabilities
(PCPID) will host a webinar/conference
call for its members to discuss the
Committee’s 2016 Report to the
President (RTP). All the PCPID
meetings, in any format, are open to the
public. This virtual meeting will be
conducted in a discussion format.
DATES: Webinar: Monday, May 2, 2016
from 3:00 p.m. to 4:30 p.m. (EST).
ADDRESSES: Webinar Web page: https://
meetingserver.hhs.gov/orion/
joinmeeting.do?ED=PkeE_
dUKbJrkcq5Y9wSWvA==.
SUMMARY:
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION AND
REASONABLE ACCOMMODATIONS NEEDS
CONTACT: Dr. MJ Karimi, PCPID Team
Lead, 330 C Street SW., 1108A,
Washington, DC 20201. Email:
MJ.Karimie@acl.hhs.gov; telephone:
202–79–7374; fax: 202–205–0402.
SUPPLEMENTARY INFORMATION:
Background: The PCPID Committee
Members met, on February 22–23, 2016,
and discussed the following four focus
areas that will be included on the 2016
RTP:
Family engagement early on in the
process to support high expectations
for students with disabilities
Federal education policies and
enforcement strategies to end
segregation in schools
Transition as a critical area for pathways
to higher education and career
development
Self-determination/Supported decisionmaking from early childhood
throughout the individual’s lifespan
The general purpose of this meeting is
to provide the members with an
opportunity to further discuss the
recommendation sections of the 2016
RTP.
Webinar/Conference Call: The
webinar is scheduled for May 2, 2016,
3:00 p.m. to 4:30 p.m. (EST) and may
end early if discussions are finished.
Instructions to Participate in the
Webinar/Conference Call on Monday,
May 2, 2016:
1. Enter the following WebEx Link:
https://meetingserver.hhs.gov/
orion/joinmeeting.do?ED=PkeE_
dUKbJrkcq5Y9wSWvA==
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
2. Click on the ‘‘join’’ button on the page
3. Enter your name and email address
4. Follow additional instructions as
provided by WebEx. This WebEx
does not require a password.
5. Please dial: (888) 469–0940; Pass
Code: 5315454 (you should put
your phone on mute during the
meeting)
Background Information on the
Committee: The PCPID acts in an
advisory capacity to the President and
the Secretary of Health and Human
Services on a broad range of topics
relating to programs, services and
support for individuals with intellectual
disabilities. The PCPID Executive Order
stipulates that the Committee shall: (1)
Provide such advice concerning
intellectual disabilities as the President
or the Secretary of Health and Human
Services may request; and (2) provide
advice to the President concerning the
following for people with intellectual
disabilities: (A) Expansion of
educational opportunities; (B)
promotion of homeownership; (C)
assurance of workplace integration; (D)
improvement of transportation options;
(E) expansion of full access to
community living; and (F) increasing
access to assistive and universally
designed technologies.
Dated: March 29, 2016.
Aaron Bishop,
Commissioner, Administration on
Disabilities.
[FR Doc. 2016–07654 Filed 4–1–16; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–E–2325]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; BRINTELLIX
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) has determined
the regulatory review period for
BRINTELLIX and is publishing this
notice of that determination as required
by law. FDA has made the
determination because of the
submission of an application to the
Director of the U.S. Patent and
Trademark Office (USPTO), Department
of Commerce, for the extension of a
patent which claims that human drug
product.
SUMMARY:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Anyone with knowledge that any
of the dates as published (in the
SUPPLEMENTARY INFORMATION section) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by June 3, 2016.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
October 3, 2016. See ‘‘Petitions’’ in the
SUPPLEMENTARY INFORMATION section for
more information.
ADDRESSES: You may submit comments
as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–E–2325 for ‘‘Determination of
Regulatory Review Period for Purposes
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19188]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07654]
[[Page 19188]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Administration on Disabilities, President's Committee for People
With Intellectual Disabilities
AGENCY: Administration for Community Living, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The President's Committee for People with Intellectual
Disabilities (PCPID) will host a webinar/conference call for its
members to discuss the Committee's 2016 Report to the President (RTP).
All the PCPID meetings, in any format, are open to the public. This
virtual meeting will be conducted in a discussion format.
DATES: Webinar: Monday, May 2, 2016 from 3:00 p.m. to 4:30 p.m. (EST).
ADDRESSES: Webinar Web page: https://meetingserver.hhs.gov/orion/joinmeeting.do?ED=PkeE_dUKbJrkcq5Y9wSWvA==.
FOR FURTHER INFORMATION AND REASONABLE ACCOMMODATIONS NEEDS CONTACT:
Dr. MJ Karimi, PCPID Team Lead, 330 C Street SW., 1108A, Washington, DC
20201. Email: MJ.Karimie@acl.hhs.gov; telephone: 202-79-7374; fax: 202-
205-0402.
SUPPLEMENTARY INFORMATION:
Background: The PCPID Committee Members met, on February 22-23,
2016, and discussed the following four focus areas that will be
included on the 2016 RTP:
Family engagement early on in the process to support high expectations
for students with disabilities
Federal education policies and enforcement strategies to end
segregation in schools
Transition as a critical area for pathways to higher education and
career development
Self-determination/Supported decision-making from early childhood
throughout the individual's lifespan
The general purpose of this meeting is to provide the members with
an opportunity to further discuss the recommendation sections of the
2016 RTP.
Webinar/Conference Call: The webinar is scheduled for May 2, 2016,
3:00 p.m. to 4:30 p.m. (EST) and may end early if discussions are
finished.
Instructions to Participate in the Webinar/Conference Call on
Monday, May 2, 2016:
1. Enter the following WebEx Link: https://meetingserver.hhs.gov/orion/joinmeeting.do?ED=PkeE_dUKbJrkcq5Y9wSWvA==
2. Click on the ``join'' button on the page
3. Enter your name and email address
4. Follow additional instructions as provided by WebEx. This WebEx does
not require a password.
5. Please dial: (888) 469-0940; Pass Code: 5315454 (you should put your
phone on mute during the meeting)
Background Information on the Committee: The PCPID acts in an
advisory capacity to the President and the Secretary of Health and
Human Services on a broad range of topics relating to programs,
services and support for individuals with intellectual disabilities.
The PCPID Executive Order stipulates that the Committee shall: (1)
Provide such advice concerning intellectual disabilities as the
President or the Secretary of Health and Human Services may request;
and (2) provide advice to the President concerning the following for
people with intellectual disabilities: (A) Expansion of educational
opportunities; (B) promotion of homeownership; (C) assurance of
workplace integration; (D) improvement of transportation options; (E)
expansion of full access to community living; and (F) increasing access
to assistive and universally designed technologies.
Dated: March 29, 2016.
Aaron Bishop,
Commissioner, Administration on Disabilities.
[FR Doc. 2016-07654 Filed 4-1-16; 8:45 am]
BILLING CODE 4154-01-P